SomnoMed Investor Relations Material
Latest events
H2 2025
SomnoMed
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from SomnoMed Limited
Access all reports
SomnoMed Limited is an Australian-based medical device company, publicly listed on the Australian Stock Exchange, specializing in the development and manufacturing of oral devices for the treatment of obstructive sleep apnea (OSA) and other sleep-related disorders. The company's product portfolio includes a range of custom-made oral appliances such as the SomnoDent series (Avant, Classic, Flex, Fusion, Herbst Advance Elite, and Herbst Advance), SomMorning Repositioner, SomnoBrux, and SomTabs for cleaning oral appliances. The company is headquartered in Sydney, Australia, and its shares are listed on the Australian Stock Exchange.
Key slides for SomnoMed Limited
H1 2025
SomnoMed Limited
H2 2025
SomnoMed Limited
Latest articles
)
Stephen J. Squeri: American Express Veteran Chairman and CEO
Stephen Squeri has spent over four decades at American Express, rising through the ranks to lead one of the world's most recognized brands.
15 Sep 2025
)
Where to? The Story of Uber
Uber's journey from rule-breaking disruptor to disciplined dual-app giant, now shaping the future of mobility, delivery, and autonomy.
5 Sep 2025
)
The Dilemma That Brought Down Kodak
Kodak helped invent digital photography but failed to embrace it. How the innovator's dilemma turned an icon into its own most famous casualty.
21 Aug 2025
Ticker symbol
SOM
Country
🇦🇺 Australia